Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
TapImmune, Inc (NASDAQ:TPIV), a clinical-stage immuno-oncology company specializing in the development of innovative peptide and gene-based immunotherapeutics for the treatment of cancer and...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.